Correction to: Neurosurgical Review

https://doi.org/10.1007/s10143-024-02435-8

The authors regret that the version of Table 3 that appears in the original published article contains some errors.

The incorrect Table 3 appears below.

Table 3. Univariate and multivariate analyses of the correlations of clinical and imaging features and therapeutic responses with overall survival

Variable

HR

P value

Univariate

  

Age (continuous)

 

0.064

Age (Categorical)

 

0.106

  ≤ 3

  

  > 3

  

Karnofsky score

0.97 (0.96–0.98)

< 0.001***

Tumor CP Size

 

0.296

Tumor volume

 

0.256

Craniocaudal dimension

 

0.366

Necrosis (55/116)

1.72 (1.20–2.46)

0.003**

Ring enhancement (52/116)

1.69 (1.18–2.43)

0.004**

Extrapontine lesion extension ratio (× 100%)

1.04 (1.02–1.06)

< 0.001***

Therapeutic response (CP reduction of 25%)

 

< 0.001***

  PR (n = 63)

1.00

 

  Non-PR (SD (n = 64)/PD (n = 7))

2.27 (1.57–3.27)

 

Therapeutic response (volume reduction of 32%)

 

< 0.001***

  PR (n = 71)

1.00

 

  Non-PR (SD (n = 56)/PD (n = 7))

2.50 (1.74–3.61)

 

Post-radiotherapy increased ring enhancement (54/134) (42/108+)

2.16 (1.50–3.10)

< 0.001***

Multivariate

  

Karnofsky score

0.97 (0. 96–0.99)

< 0.001***

Necrosis

1.55 (1.08–2.23)

0.017*

Extrapontine lesion extension ratio (× 100%)

1.03 (1.01–1.05)

0.006**

Therapeutic response (volume reduction of 32%)

 

0.008**

  PR

1.00

 

  Non-PR (SD/PD)

1.73 (1.15–2.61)

 

* P < 0.05, ** P < 0.01, *** P < 0.001.

Jiangfen ZhouAbbreviations: PR, partial response; SD, stable disease; PD, progressive disease; CP, cross-product; HR, hazards ratio

The correct Table 3 is shown below.

Table 3. Univariate and multivariate analyses of the correlations of clinical and imaging features and therapeutic responses with overall survival

Variable

HR

P value

Univariate

  

Age (continuous)

 

0.064

Age (Categorical)

 

0.106

  ≤ 3

  

  > 3

  

Karnofsky score

0.97 (0.96–0.98)

< 0.001***

Tumor CP Size

 

0.296

Tumor volume

 

0.256

Craniocaudal dimension

 

0.366

Necrosis (55/134)

1.72 (1.20–2.46)

0.003**

Ring enhancement (52/134)

1.69 (1.18–2.43)

0.004**

Extrapontine lesion extension ratio (× 100%)

1.04 (1.02–1.06)

< 0.001***

Therapeutic response (CP reduction of 25%)

 

< 0.001***

  PR (n = 63)

1.00

 

  Non-PR (SD (n = 64)/PD (n = 7))

2.27 (1.57–3.27)

 

Therapeutic response (volume reduction of 32%)

 

< 0.001***

  PR (n = 71)

1.00

 

  Non-PR (SD (n = 56)/PD (n = 7))

2.50 (1.74–3.61)

 

Post-radiotherapy increased ring enhancement (54/134)

2.16 (1.50–3.10)

< 0.001***

Multivariate

  

Karnofsky score

0.97 (0. 96–0.99)

< 0.001***

Necrosis

1.55 (1.08–2.23)

0.017*

Extrapontine lesion extension ratio (× 100%)

1.03 (1.01–1.05)

0.006**

Therapeutic response (volume reduction of 32%)

 

0.008**

  PR

1.00

 

  Non-PR (SD/PD)

1.73 (1.15–2.61)

 
  1. * P < 0.05, ** P < 0.01, *** P < 0.001.
  2. PR, partial response; SD, stable disease; PD, progressive disease; CP, cross-product; HR, hazards ratio
  3. The original article has been corrected.